Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617 1643 1644 1657
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18297451 | TUMOR VACCINATION IN COMBINATION WITH HEMATOPOIETIC CELL TRANSPLANTATION FOR CANCER THERAPY | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17887828 | UBIQUITIN LIGASE KPC1 PROMOTES PROCESSING OF P105 NF-KAPPAB1 TO P50, ELICITING STRONG TUMOR SUPPRESSION | Non-Final OA | Technion Research & Development Foundation Limited. |
| 18039369 | CANCER IMMUNOTHERAPIES TO PROMOTE HYPERACUTE REJECTION | Non-Final OA | CORNELL UNIVERSITY |
| 18345385 | Targeted Radiotherapy Chelates for In Situ Immune Modulated Cancer Vaccination | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18182850 | Using Targeted Radiotherapy (TRT) to Drive Anti-Tumor Immune Response to Immunotherapies | Non-Final OA | Wisconsin Alumni Research Foundation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy